®
TaxReply India Private Limited
Best GST Library
Subscription Plans
TaxGPT
GST News | Updates
GST Calendar
GST Case Laws
GST Case Laws Sitemap
GST Notifications, Circulars, Releases etc.
Act & Rules
Act & Rules (Multi-view)
GST Rates
HSN Codes New
GST Forms
GST Diary
GST Notebook
GST Fees Manager
GST Council Meetings
GST Set-off Calculator
ITC Reversal Calculator
E-invoice Calculator
Inverted Duty Calculator
GSTR-3B Manual
GSTR-9 Manual
GSTR-9C Manual
Full Site Search
E-way Bill
Finance Bill
GST e-books
®
WhatsappGroup
@taxreply
TaxReplyCommunity
GST Rate of HSN 300490
(HSN Codes as per First Schedule To Customs Tariff Act, 1975)
| HSN Code | HSN Description | GST Rate | |
|---|---|---|---|
Chapter 30 |
PHARMACEUTICAL PRODUCTS | ||
3004 |
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale | ||
300490 |
- | Other: | |
30049011 |
---- | Of Ayurvedic system | |
30049012 |
---- | Of Unani system | |
30049013 |
---- | Of Siddha system | |
30049014 |
---- | Of Homoeopathic system | |
30049015 |
---- | Of Bio-chemic system | |
30049021 |
---- | Anthelmintics and preparations thereof | |
30049022 |
---- | Metronidazole | |
30049023 |
---- | Tinidazole | |
30049024 |
---- | Secnidazole | |
30049025 |
---- | Diluxamide furoate | |
30049026 |
---- | Sodium stibogluconate | |
30049027 |
---- | Pentamidine | |
30049029 |
---- | Other | |
30049031 |
---- | Promethazine, chlorpheniramine, astemizole and ceteirizine | |
30049032 |
---- | Sodium bicarbonate, magnesium hydroxide (milk of magnesia), magnesium carbonate, magnesium trisilicate, aluminium hydroxide gel, magaldarate and combinations thereof | |
30049033 |
---- | Cimetidine, rantidine, nizatidine and roxatidine | |
30049034 |
---- | Omeprazole and lunsoprazole | |
30049035 |
---- | Dicyclomine, metoclopramide and dexame thasone and ondansetron | |
30049036 |
---- | Chenodiol and ursodiol | |
30049039 |
---- | Other | |
30049041 |
---- | Cyclophosphamide | |
30049042 |
---- | Methotrexate, 5-fluorouracil (5-FU) and ftorafur | |
30049043 |
---- | Bincristine and vinblastine | |
30049044 |
---- | Paclitaxel docetaxel | |
30049045 |
---- | Etoposide | |
30049046 |
---- | Actinomycin D Dactinomycin and doxorubicin | |
30049047 |
---- | L-Asparaginase, cisplatin and carboplatin | |
30049048 |
---- | Tamoxifen | |
30049049 |
---- | Other | |
30049051 |
---- | Isoniazid | |
30049052 |
---- | Rifampicin | |
30049053 |
---- | Pyrazinamide and ethambutol | |
30049054 |
---- | Streptomycin | |
30049055 |
---- | Dapsone (DDS), acedapsone (DADDS), solopsone and clofazimine | |
30049056 |
---- | Chloroquine, amodiaquine, mefloquine, quinine, chloroguamide, pyrimethamine | |
30049057 |
---- | Other antitubercular drugs | |
30049058 |
---- | Other antileprotic drugs | |
30049059 |
---- | Other antimalarial drugs | |
30049061 |
---- | Analgin with or without other compounds such as paracetamol | |
30049062 |
---- | Acetyl salicylic acid (aspirin) and formulations thereof | |
30049063 |
---- | Ibuprofen with or without paracetamol or other compounds | |
30049064 |
---- | Oxyphen butazone, phenyl butazone and formulations thereof | |
30049065 |
---- | Indomethacin | |
30049066 |
---- | Mephenamic acid, dactofenac sodium, piroxicam, tenoxicam and meloxicam | |
30049067 |
---- | Ketorolac, nimesulide, nabumetone and nefopam | |
30049069 |
---- | Other | |
30049071 |
---- | Captopril, enalapril, lisinopril, perindopril and ramipril | |
30049072 |
---- | Verapamil, nifedipine, amlodipine and lacidipine | |
30049073 |
---- | Losartan | |
30049074 |
---- | Propranolol, metoprolol, atenolol and labetalol | |
30049075 |
---- | Prazosin, terazosin, phentolamine and phenoxybenzamine | |
30049076 |
---- | Clonidine, methyldopa | |
30049077 |
---- | Hydralazine, minoxidil and diazoxide | |
30049079 |
---- | Other | |
30049081 |
---- | Phenobarbitone, mephobarbitone, primidone, phenytoin, carbamazepine, ethosuccimide, valporic acid (sodium valporate), diazepam, lamotrigine, gabapentin, bigabatrin, phenacemide, trimethadione and acetazolamide | |
30049082 |
---- | Other antiepiliptic drugs | |
30049083 |
---- | Sulpha drugs not elsewhere specified or included | |
30049084 |
---- | Preparations of enzymes | |
30049085 |
---- | Veterinary medicinal preparations, not for human use, not elsewhere specified or included | |
30049086 |
---- | Oral rehydration salts | |
30049087 |
---- | Antibacterial formulations, not elsewhere specified or included | |
30049088 |
---- | Sedatives | |
30049089 |
---- | Tranquilizers | |
30049091 |
---- | Salbutamol, terbutaline, ephedrine, salmeterol and methyl xanthimes | |
30049092 |
---- | Plasma expanders | |
30049093 |
---- | Chloropheniramine maleate, with or without other compounds (excluding steriods and alkaloids) | |
30049094 |
---- | Theophylline, aminophylline and other broncho dilators | |
30049095 |
---- | Carcino-chemotherapeutic drugs not elsewhere specified or included | |
30049096 |
---- | Ketamine | |
30049099 |
---- | Other |
Apr
24 Apr
☑ Quarterly | GSTR-3B
GSTR-3B for the Quarter Jan - Mar 2025 (QRMP Taxpayers < 5 Cr - Rule 61) - Category II States.
* State Category II - Himachal Pradesh, Punjab, Uttarakhand, Haryana, Rajasthan, Uttar Pradesh, Bihar, Sikkim, Arunachal Pradesh, Nagaland, Manipur, Mizoram, Tripura, Meghalaya, Assam, West Bengal, Jharkhand or Odisha or the Union territories of Jammu and Kashmir, Ladakh, Chandigarh and Delhi.
25 Apr
☑ Half-Yearly | ITC-04
ITC-04 for the half year (Oct - Mar 2025) (For taxpayers > 5 Cr. Turnover) - Rule 45.
☑ Annual | ITC-04
ITC-04 for complete FY 2024-25 (For taxpayers <= 5 Cr. Turnover) - Rule 45.
28 Apr
☑ Monthly | GSTR-11
GSTR-11 for the m/o Mar 2025 (Statement of inward supplies by persons having Unique Identification Number (UIN)).
30 Apr
☑ Quarterly | QRMP
Last date for opt-in / opt-out QRMP Scheme for quarter Apr - June 2025 (Rule 61A)